Latasha Little
University of Texas MD Anderson Cancer Center
67 Papers
94 Citations
Latasha Little is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Biology & Medicine. The author has an hindex of 18, co-authored 53 publications. Previous affiliations of Latasha Little include Duke University.
Chat about Author
Papers
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing
Jianjun Zhang,Junya Fujimoto,Jianhua Zhang,David C. Wedge,Xingzhi Song,Jiexin Zhang,Sahil Seth,Chi Wan Chow,Yu Cao,Curtis Gumbs,Kathryn A. Gold,Neda Kalhor,Latasha Little,Harshad S. Mahadeshwar,Cesar A. Moran,Alexei Protopopov,Huandong Sun,Jiabin Tang,Xifeng Wu,Yuanqing Ye,William N. William,J. Jack Lee,John V. Heymach,Waun Ki Hong,Stephen G. Swisher,Ignacio I. Wistuba,Andrew Futreal,Andrew Futreal +27 more
TL;DR: WES data indicate that a larger subclonal mutation fraction may be associated with increased likelihood of postsurgical relapse in patients with localized lung adenocarcinomas, and different mutations are present in different regions of any given lung cancer, and their pattern may predict patient relapse.
973
Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance
Whijae Roh,Pei Ling Chen,Alexandre Reuben,Christine N. Spencer,Peter A. Prieto,John P. Miller,Vancheswaran Gopalakrishnan,Feng Wang,Zachary A. Cooper,Sangeetha M. Reddy,Curtis Gumbs,Latasha Little,Qing Chang,Wei Shen Chen,Khalida Wani,Mariana Petaccia de Macedo,Eveline Chen,Jacob Austin-Breneman,Hong Jiang,Jason Roszik,Michael T. Tetzlaff,Michael A. Davies,Jeffrey E. Gershenwald,Hussein Abdul-Hassan Tawbi,Alexander J. Lazar,Patrick Hwu,Wen-Jen Hwu,Adi Diab,Isabella C. Glitza,Sapna Pradyuman Patel,Scott E. Woodman,Rodabe N. Amaria,Victor G. Prieto,Jianhua Hu,Padmanee Sharma,James P. Allison,Lynda Chin,Jianhua Zhang,Jennifer A. Wargo,P. Andrew Futreal +39 more
TL;DR: Deep molecular profiling of melanoma patients treated with sequential checkpoint blockade demonstrated that a more clonal T cell repertoire was predictive of response to PD-1 but not CTLA-4 blockade, suggesting the potential utility of a combinatorial biomarker to optimize patient care with checkpoint blockade therapy.
De novo mutations in ATP1A3 cause alternating hemiplegia of childhood
Erin L. Heinzen,Kathryn J. Swoboda,Yuki Hitomi,Fiorella Gurrieri,Sophie Nicole,Sophie Nicole,Sophie Nicole,Boukje de Vries,F Danilo Tiziano,Bertrand Fontaine,Bertrand Fontaine,Bertrand Fontaine,Nicole M. Walley,Sinéad Heavin,Eleni Panagiotakaki,Stefania Fiori,Emanuela Abiusi,Lorena Di Pietro,Matthew T. Sweney,Tara M. Newcomb,Louis Viollet,Chad D. Huff,Lynn B. Jorde,Sandra P. Reyna,Kelley J. Murphy,Kevin V. Shianna,Curtis Gumbs,Latasha Little,Kenneth Silver,Louis J. Ptáček,Joost Haan,Michel D. Ferrari,Ann M. E. Bye,Geoffrey K. Herkes,Charlotte M Whitelaw,David Webb,Bryan Lynch,Peter Uldall,Mary D King,Ingrid E. Scheffer,Ingrid E. Scheffer,Giovanni Neri,Alexis Arzimanoglou,Alexis Arzimanoglou,Alexis Arzimanoglou,Arn M. J. M. van den Maagdenberg,Sanjay M. Sisodiya,Mohamad A. Mikati,David Goldstein +48 more
TL;DR: De novo ATP1A3 mutations are identified as the primary cause ofAlternating hemiplegia of childhood and insight into disease pathophysiology is offered by expanding the spectrum of phenotypes associated with mutations in ATP 1A3.
Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics.
Kiyomi Morita,Kiyomi Morita,Feng Wang,Katharina Jahn,Katharina Jahn,Tianyuan Hu,Tomoyuki Tanaka,Yuya Sasaki,Jack Kuipers,Jack Kuipers,Sanam Loghavi,Sa A. Wang,Yuanqing Yan,Ken Furudate,Ken Furudate,Jairo Matthews,Latasha Little,Curtis Gumbs,Jianhua Zhang,Xingzhi Song,Erika Thompson,Keyur P. Patel,Carlos E. Bueso-Ramos,Courtney D. DiNardo,Farhad Ravandi,Elias Jabbour,Michael Andreeff,Jorge E. Cortes,Kapil N. Bhalla,Guillermo Garcia-Manero,Hagop M. Kantarjian,Marina Konopleva,Daisuke Nakada,Nicholas Navin,Niko Beerenwinkel,Niko Beerenwinkel,P. Andrew Futreal,Koichi Takahashi +37 more
TL;DR: Using a single-cell DNA sequencing, the clonal architecture and mutational histories of 123 acute myeloid leukemia (AML) patients are reported, revealing cell-level mutation co-occurrence and enables reconstruction ofmutational histories characterized by linear and branching patterns of clonal evolution.
Recurrent PTPRB and PLCG1 mutations in angiosarcoma
Sam Behjati,Sam Behjati,Patrick S. Tarpey,Helen Sheldon,Inigo Martincorena,Peter Van Loo,Peter Van Loo,Gunes Gundem,David C. Wedge,Manasa Ramakrishna,Susanna L. Cooke,Nischalan Pillay,Nischalan Pillay,Hans Kristian Moen Vollan,Hans Kristian Moen Vollan,Hans Kristian Moen Vollan,Elli Papaemmanuil,Hans Koss,Hans Koss,Tom D. Bunney,Claire Hardy,Olivia Joseph,Sancha Martin,Laura Mudie,Adam Butler,Jon W. Teague,M Patil,Graham Steers,Yu Cao,Curtis Gumbs,Davis R. Ingram,Alexander J. Lazar,Latasha Little,Harshad S. Mahadeshwar,Alexei Protopopov,Ghadah A. Al Sannaa,Sahil Seth,Xingzhi Song,Jiabin Tang,Jianhua Zhang,Vinod Ravi,Keila E. Torres,Bhavisha Khatri,Dina Halai,Ioannis Roxanis,Daniel Baumhoer,Roberto Tirabosco,M Fernanda Amary,Chris Boshoff,Chris Boshoff,Ultan McDermott,Matilda Katan,Michael R. Stratton,P. Andrew Futreal,Adrienne M. Flanagan,Adrienne M. Flanagan,Adrian L. Harris,Adrian L. Harris,Peter J. Campbell,Peter J. Campbell +59 more
TL;DR: This work employed whole-genome, whole-exome and targeted sequencing to study the somatic changes underpinning primary and secondary angiosarcoma, and identified recurrent mutations in two genes, PTPRB and PLCG1, which are intimately linked to angiogenesis.